LINNEA 315CSE
LIVE

Serial Number

88589105

Owner

LINNEA SA

Attorney

Perla M. Kuhn

Filing Date

Aug 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

LINNEA 315CSE Trademark

Serial Number: 88589105 • Registration: 6351234

LINNEA 315CSE is a trademark filed by LINNEA SA on August 22, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LINNEA SA

Via Cantonale
Riazzino CH-6595 , CH

Entity Type: 03

Trademark Details

Filing Date

August 22, 2019

Registration Date

May 18, 2021

Published for Opposition

July 21, 2020

Goods & Services

Chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; botanical extracts, active substances and active chemical ingredients for use in the manufacture of veterinary preparations; plant extracts, active compounds and active chemical ingredients for use in the manufacture of pharmaceuticals; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; chemicals for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and dietary supplements; food preserving chemicals; plant extracts, active substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements

Pharmaceuticals derived from botanical and plant extracts; pharmaceuticals derived from botanical and plant extracts for veterinary purposes; pharmaceuticals derived from botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; medicines for veterinary purposes; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts for pharmaceutical and veterinary purposes; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system; plant extracts, active substances and active chemical ingredients for veterinary use; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the cosmetics industry; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders, metabolic disorders, cardiovascular disorders, respiratory diseases, gastrointestinal disorders, disorders of the central nervous system, disorders of the immune system

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 18, 2026 REM1
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NURC
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 26, 2024 ERRR
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 23, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 12, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Mar 6, 2024 ES7R
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 9, 2021 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 9, 2021 AITU
NOTICE OF ALLOWANCE CANCELLED
Jan 20, 2021 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jan 20, 2021 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2020 CRFA
ASSIGNED TO LIE
Jun 11, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 4, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2019 NWOS
NEW APPLICATION ENTERED
Aug 26, 2019 NWAP